InsidersTradesSigma
Total declarations
Companies
▲ Purchases (18 ops.)
▼ Sales (17 ops.)
Insider track record
OtherDisclosed buys
18
Disclosed sells
17
T+90 hit rate
0%
T+90 mean return
-7.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Viking Global Investors Lp. Director active across 14 companies, notably Rallybio Corp. In total, 51 filings have been recorded. Breakdown: 18 buys · 17 sells. Total volume traded: €1.1bn. Activity tracked since 2 September 2021. The latest transaction was filed on 7 October 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Viking Global Investors Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
308,643 shares@ US$32.25100.0% of flowCommon StockSEC:0000905148-25-003555:0
3,500,000 shares@ US$44.0046.8% of flowCommon StockSEC:0000905148-25-002297:0
3,065,616 shares@ US$34.9068.8% of flowCommon StockSEC:0000905148-25-000306:0
39,032 shares@ US$38.150.1% of flowCommon StockSEC:0000905148-24-001732:1
39,032 shares@ US$38.150.1% of flowCommon StockSEC:0000905148-24-001733:1
1,912,750 shares@ US$38.156.5% of flowCommon StockSEC:0000905148-24-001732:0
1,912,750 shares@ US$38.156.5% of flowCommon StockSEC:0000905148-24-001733:0
6,305,866 shares@ US$30.0081.4% of flowCommon StockSEC:0000905148-24-001667:0
2,977,845 shares@ US$34.259.0% of flowCommon StockSEC:0000905148-24-000919:0
2,977,845 shares@ US$34.259.0% of flowCommon StockSEC:0000905148-24-000920:0
8,036,862 shares@ US$24.6017.4% of flowCommon StockSEC:0000905148-24-000844:0
8,036,862 shares@ US$24.6017.4% of flowCommon StockSEC:0000905148-24-000843:0
4,899,144 sharesCommon StockSEC:0000905148-24-000814:0
4,899,144 sharesCommon StockSEC:0000905148-24-000813:0
540,000 shares@ US$19.5343.8% of flowCommon StockSEC:0000905148-24-000092:0
6,300,817 shares@ US$31.3017.0% of flowCommon StockSEC:0000905148-24-000079:0
6,300,817 shares@ US$31.3017.0% of flowCommon StockSEC:0000905148-24-000080:0
864,509 sharesCommon StockSEC:0000905148-23-000958:0
864,509 sharesCommon StockSEC:0000905148-23-000959:0
511,627 shares@ US$19.354.3% of flowCommon StockSEC:0000905148-23-000804:0
Canonical exit: 26 Nov 2023 (T+90)
1,500,000 shares@ US$35.0031.2% of flowCommon StockSEC:0001140361-23-035288:0
110,756 shares@ US$9.90100.0% of flowCommon SharesSEC:0001140361-23-031459:0
850,000 shares@ US$16.0056.2% of flowCommon StockSEC:0001140361-23-024202:0
Canonical exit: 7 Aug 2023 (T+90)
2,459,880 sharesClass A Ordinary SharesSEC:0001140361-22-043107:0
567,532 shares@ US$10.08100.0% of flowCommon StockSEC:0001140361-22-040057:0
Canonical exit: 31 Jan 2023 (T+90)
25 of 51 declarations
About Viking Global Investors Lp
VIKING GLOBAL INVESTORS LP is a declarant with 51 filings in total. In the 51 recent filings sampled, the stated aggregate amounts are EUR 57,986,313 of buys and EUR 1,023,815,559 of sells, with filings ranging from 2016-02-08 to 2025-10-09. The companies listed are Editas Medicine, Inc., APi Group Corp, RayzeBio, Inc., BridgeBio Pharma, Inc., Inhibrx, Inc. and 4D Molecular Therapeutics, Inc., and the stated role for APi Group Corp is 10% Owner.
